Because of the complexity of endocan’s interactions with a variety of factors related to atherosclerosis, one might raise the question of whether endocan is a bystander or a critical player in the role of inflammation-mediated vasculopathy in PAD. Here, ESM1 is linked to peripheral arterial disease.